Cartesian Therapeutics In... (RNAC)
17.58
-1.26 (-6.69%)
At close: Mar 03, 2025, 3:59 PM
17.50
-0.46%
After-hours: Mar 03, 2025, 04:00 PM EST
Cartesian Therapeutics Revenue
Cartesian Therapeutics reported an annual revenue of $26M, reflecting a -76.53% growth. For the quarter ending September 30, 2024, Cartesian Therapeutics generated $387K in revenue.
Revenue (ttm)
$26M
Revenue Growth
-76.53%
Price / Sales Ratio
3.91
Revenue / Employee
$702.81K
Employees
37
Market Cap
452.25M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2023 | 26M | -76.53% |
| Dec 31, 2022 | 110.78M | +30.21% |
| Dec 31, 2021 | 85.08M | +412.60% |
| Dec 31, 2020 | 16.6M | n/a |